[HTML][HTML] Parkinson's disease drug therapies in the clinical trial pipeline: 2021 update
K McFarthing, G Rafaloff, MAS Baptista… - Journal of …, 2021 - content.iospress.com
Background: Despite the COVID-19 pandemic, there has been considerable activity in the
clinical development of novel and improved drug-based therapies for the neurodegenerative …
clinical development of novel and improved drug-based therapies for the neurodegenerative …
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update.
K McFarthing, G Rafaloff, MAS Baptista… - Journal of Parkinson's …, 2021 - europepmc.org
Background Despite the COVID-19 pandemic, there has been considerable activity in the
clinical development of novel and improved drug-based therapies for the neurodegenerative …
clinical development of novel and improved drug-based therapies for the neurodegenerative …
[PDF][PDF] Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
K McFarthinga, G Rafaloffb… - Journal of …, 2021 - scienceopen.com
Background: Despite the COVID-19 pandemic, there has been considerable activity in the
clinical development of novel and improved drug-based therapies for the neurodegenerative …
clinical development of novel and improved drug-based therapies for the neurodegenerative …
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
K McFarthing, G Rafaloff, MAS Baptista… - Journal of Parkinson's …, 2021 - cir.nii.ac.jp
抄録< jats: p> Background: Despite the COVID-19 pandemic, there has been considerable
activity in the clinical development of novel and improved drug-based therapies for the …
activity in the clinical development of novel and improved drug-based therapies for the …
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
K McFarthing, G Rafaloff… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Despite the COVID-19 pandemic, there has been considerable activity in the
clinical development of novel and improved drug-based therapies for the neurodegenerative …
clinical development of novel and improved drug-based therapies for the neurodegenerative …
[HTML][HTML] Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
K McFarthing, G Rafaloff, MAS Baptista… - Journal of Parkinson's …, 2021 - ncbi.nlm.nih.gov
Background: Despite the COVID-19 pandemic, there has been considerable activity in the
clinical development of novel and improved drug-based therapies for the neurodegenerative …
clinical development of novel and improved drug-based therapies for the neurodegenerative …
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
K McFarthinga, G Rafaloffb… - Journal of …, 2021 - content.iospress.com
Background: Despite the COVID-19 pandemic, there has been considerable activity in the
clinical development of novel and improved drug-based therapies for the neurodegenerative …
clinical development of novel and improved drug-based therapies for the neurodegenerative …